New Nuclear Medicine Research Previewed

Upcoming Journal of Nuclear Medicine studies explore cancer imaging, lung cancer prognosis, neuroendocrine tumor therapy, and liver cancer detection.

Apr. 11, 2026 at 1:20am

Got story updates? Submit your updates here. ›

A highly structured abstract painting in soft, earthy tones of green, blue, and brown, resembling a massive scientific diagram with sweeping geometric arcs, concentric circles, and precise spirals, conceptually representing the complex forces and innovations in nuclear medicine and molecular imaging.Innovative nuclear medicine technologies are enabling more precise cancer diagnosis, treatment, and outcome prediction through advanced molecular imaging techniques.Reston Today

The Journal of Nuclear Medicine has published new research ahead of print, including studies on developing better cancer imaging and therapy tools, using brain PET scans to predict lung cancer survival, tracking tumor receptor activity after neuroendocrine tumor treatment, and creating a PET tracer to improve liver cancer detection.

Why it matters

These studies showcase the latest advancements in nuclear medicine and molecular imaging, which are critical for improving cancer diagnosis, treatment planning, and patient outcomes. The research highlights how new radiopharmaceuticals, PET imaging techniques, and data analysis methods can provide more precise, personalized care for cancer patients.

The details

The new JNM studies cover a range of topics in nuclear medicine and molecular imaging for cancer. Researchers developed a new chelator compound called Dar3A that improves upon the widely used DOTA for creating targeted cancer imaging and therapy agents. Another team found that analyzing brain glucose uptake on PET scans, rather than just tumor activity, could help predict survival in advanced lung cancer patients. A third study tracked how neuroendocrine tumors progress after targeted radionuclide therapy, monitoring somatostatin receptor levels. Finally, scientists engineered a PET tracer targeting the CD147 protein to enhance liver cancer detection.

  • The new research was published ahead-of-print by The Journal of Nuclear Medicine on April 10, 2026.

The players

The Journal of Nuclear Medicine (JNM)

A scientific journal published by the Society of Nuclear Medicine and Molecular Imaging, an international organization dedicated to advancing nuclear medicine, molecular imaging, and precision medicine.

Society of Nuclear Medicine and Molecular Imaging

An international scientific and medical organization that publishes JNM and promotes research and innovation in nuclear medicine, molecular imaging, and theranostics.

Got photos? Submit your photos here. ›

The takeaway

The new JNM research demonstrates how nuclear medicine and molecular imaging continue to drive progress in precision cancer care, from developing better imaging and therapeutic agents to uncovering new prognostic biomarkers. These innovations hold promise for more personalized and effective management of various cancer types.